MEDICINOVA, INC. Current Liabilities
MEDICINOVA, INC. (MNOV) had Current Liabilities of $2.96 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $2.96M.
- 2026-03-31: Liabilities, Current $3.10M.
- 2025-12-31: Liabilities, Current $3.80M.
- 2025-09-30: Liabilities, Current $3.34M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $2.96M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $3.10M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $3.80M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $3.34M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $2.65M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $2.13M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $2.96M 10-K · filed 2026-03-10 |
| 2024-09-30 | $2.60M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $2.49M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.51M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $3.28M 10-K · filed 2025-02-19 |
| 2023-09-30 | $2.80M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $2.82M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $2.72M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $3.19M 10-K · filed 2024-02-15 |
| 2022-09-30 | $4.53M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $3.84M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $2.98M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $2.83M 10-K/A · filed 2023-03-28 |
| 2021-09-30 | $4.20M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $2.47M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.83M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $2.19M 10-K · filed 2022-02-16 |
| 2020-09-30 | $1.80M 10-Q · filed 2020-10-26 |
| 2020-06-30 | $2.77M 10-Q · filed 2020-07-28 |
| 2020-03-31 | $1.79M 10-Q · filed 2020-04-23 |
| 2019-12-31 | $2.23M 10-K · filed 2021-02-19 |
| 2019-09-30 | $1.73M 10-Q · filed 2019-10-24 |
| 2019-06-30 | $1.79M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $1.37M 10-Q · filed 2019-04-25 |
| 2018-12-31 | $2.19M 10-K · filed 2020-02-13 |
| 2018-09-30 | $1.80M 10-Q · filed 2018-10-25 |
| 2018-06-30 | $1.57M 10-Q · filed 2018-07-23 |
| 2018-03-31 | $1.20M 10-Q · filed 2018-04-25 |
| 2017-12-31 | $2.88M 10-K · filed 2019-02-13 |
| 2017-09-30 | $1.74M 10-Q · filed 2017-10-23 |
| 2017-06-30 | $1.42M 10-Q · filed 2017-07-26 |
| 2017-03-31 | $1.02M 10-Q · filed 2017-04-26 |
| 2016-12-31 | $1.63M 10-K · filed 2018-02-13 |
| 2016-09-30 | $1.38M 10-Q · filed 2016-10-25 |
| 2016-06-30 | $1.33M 10-Q · filed 2016-07-26 |
| 2016-03-31 | $1.05M 10-Q · filed 2016-04-27 |
| 2015-12-31 | $1.49M 10-K · filed 2017-02-14 |
| 2015-09-30 | $1.30M 10-Q · filed 2015-10-29 |
| 2015-06-30 | $1.11M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $853.03K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $1.59M 10-K · filed 2016-02-25 |
| 2014-09-30 | $1.13M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $1.10M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $901.82K 10-Q · filed 2014-05-08 |
| 2013-12-31 | $460.44K 10-K · filed 2015-03-12 |
| 2013-09-30 | $1.10M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $1.08M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $948.15K 10-Q · filed 2013-05-08 |
| 2012-12-31 | $1.04M 10-K · filed 2014-03-27 |
| 2012-09-30 | $1.16M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $3.21M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $2.74M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $3.70M 10-K · filed 2013-03-28 |
| 2011-09-30 | $3.43M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $2.45M 10-Q · filed 2011-08-15 |
| 2010-12-31 | $36.79M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |